how many people are on glp-1 drugs use peaks in middle age, then drops at 65 how many people use glp

The effects of semaglutide on kidney oxygenation, albuminuria and eGFR will be assessed in people with type 1 diabetes as part of the REMODEL-T1D mechanistic trial (NCT05822609)

Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes

Prioritizing protein intake at 0.7 to 1.0 grams per pound of body weight, staying well hydrated, exercising consistently with an emphasis on resistance training, sleeping seven to nine hours nightly, and managing stress all meaningfully accelerate results

If weight loss stalls before reaching your target, switching to tirzepatide often restarts progress

Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF

Diabetologia 66 , 20072016 (2023)